Yonghe Medical Group Future Growth
Future criteria checks 4/6
Yonghe Medical Group is forecast to grow earnings and revenue by 102.9% and 15.9% per annum respectively. EPS is expected to grow by 103.5% per annum. Return on equity is forecast to be 12.4% in 3 years.
Key information
102.9%
Earnings growth rate
103.5%
EPS growth rate
| Healthcare earnings growth | 19.6% |
| Revenue growth rate | 15.9% |
| Future return on equity | 12.4% |
| Analyst coverage | Low |
| Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks
Mar 31
Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?
Oct 19The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically
Sep 08Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 19Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture
Mar 31Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,908 | 160 | N/A | 97 | 1 |
| 12/31/2025 | 2,487 | 28 | N/A | 19 | 2 |
| 12/31/2024 | 2,134 | -162 | N/A | 326 | 2 |
| 12/31/2023 | 1,777 | -538 | -188 | -17 | N/A |
| 9/30/2023 | 1,635 | -430 | -246 | -35 | N/A |
| 6/30/2023 | 1,492 | -322 | -304 | -54 | N/A |
| 3/31/2023 | 1,453 | -203 | -328 | -81 | N/A |
| 12/31/2022 | 1,413 | -84 | -352 | -109 | N/A |
| 9/30/2022 | 1,638 | 6 | -206 | 15 | N/A |
| 6/30/2022 | 1,863 | 95 | -59 | 139 | N/A |
| 3/31/2022 | 2,016 | 107 | 94 | 288 | N/A |
| 12/31/2021 | 2,169 | 118 | 247 | 437 | N/A |
| 9/30/2021 | 2,129 | 121 | 301 | 492 | N/A |
| 6/30/2021 | 2,090 | 125 | 355 | 546 | N/A |
| 3/31/2021 | 1,864 | 136 | 357 | 524 | N/A |
| 12/31/2020 | 1,638 | 147 | 359 | 502 | N/A |
| 12/31/2019 | 1,224 | 36 | 74 | 182 | N/A |
| 12/31/2018 | 934 | 54 | 58 | 195 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2279 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.2%).
Earnings vs Market: 2279 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2279 is expected to become profitable in the next 3 years.
Revenue vs Market: 2279's revenue (15.9% per year) is forecast to grow faster than the Hong Kong market (8.2% per year).
High Growth Revenue: 2279's revenue (15.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2279's Return on Equity is forecast to be low in 3 years time (12.4%).